Marker Therapeutics Inc (MRKR)

[Rkmatters]

Hi Bean,
The press release this week indicates the plan to phase II studies on FRa, in TNBC and Ovarian Cancer.

Studies, is plural, therefore, we can expect two in FRa alone. They suggested several in June, think we understood this as FRa, HER-neu trials and infectious diseases. :)

Sounds like they're close, use of "immediate plan" in second 1/2 of 2015.

Original plan was one FRa trial in Q3 of 2015 only, to which we are in. Now we are at two. :)

My guess:

First FRa trial will be this quarter on TNBC. The peptides collection has been on-going, and they mention this trial in documents, as Q3.

Next FRa trial will be on Ovarian later this year, Q4. And I imagine since they added this, it is why they stated "studies" as second 1/2 of this year.

Third trial:

HER2-Neu will be late this year/early next.

Do not know timing on the fourth trial. Though believe it is this year as well.

My $.02